Literature DB >> 15001923

Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass.

Paulo Roberto B Evora, Ricardo L Levin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001923     DOI: 10.1016/j.jtcvs.2003.09.046

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  5 in total

1.  Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.

Authors:  J Hunter Mehaffey; Lily E Johnston; Robert B Hawkins; Eric J Charles; Leora Yarboro; John A Kern; Gorav Ailawadi; Irving L Kron; Ravi K Ghanta
Journal:  Ann Thorac Surg       Date:  2017-05-24       Impact factor: 4.330

Review 2.  Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.

Authors:  Jayme A Farina Junior; Andrea Carla Celotto; Marcelo Felix da Silva; Paulo Roberto B Evora
Journal:  Med Sci Monit       Date:  2012-05

Review 3.  Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised.

Authors:  Paulo Roberto Barbosa Evora; Lafaiete Alves Junior; Cesar Augusto Ferreira; Antônio Carlos Menardi; Solange Bassetto; Alfredo José Rodrigues; Adilson Scorzoni Filho; Walter Vilella de Andrade Vicente
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jan-Mar

4.  The values shown on optical technology-based patient monitors must be cautiously interpreted: intravenous dye-induced errors.

Authors:  Hee-Pyoung Park
Journal:  Korean J Anesthesiol       Date:  2015-04

5.  Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery.

Authors:  Aly Makram Habib; Ahmed Galal Elsherbeny; Rayd Abdelaziz Almehizia
Journal:  Indian J Crit Care Med       Date:  2018-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.